{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:53:52Z","timestamp":1784235232956,"version":"3.55.0"},"reference-count":53,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2024.1884","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T12:47:14Z","timestamp":1730292434000},"source":"Crossref","is-referenced-by-count":6,"title":["Design, synthesis, biological and <i>in silico<\/i> evaluation of 3\u2011carboxy\u2011coumarin sulfonamides as potential antiproliferative agents targeting HDAC6"],"prefix":"10.3892","volume":"22","author":[{"given":"Jos\u00e9","family":"Madrigal\u2011Angulo","sequence":"first","affiliation":[{"name":"Faculty of Chemical Sciences, University of Colima, Coquimatl\u00e1n 28400, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Hern\u00e1ndez\u2011Fuentes","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Parra\u2011Delgado","sequence":"additional","affiliation":[{"name":"Faculty of Chemical Sciences, University of Colima, Coquimatl\u00e1n 28400, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marycruz","family":"Olvera\u2011Vald\u00e9z","sequence":"additional","affiliation":[{"name":"Laboratorio de Qu\u00edmica Supramolecular y Nanociencias, Unidad Profesional Interdisciplinaria de Biotecnolog\u00eda, Instituto Polit\u00e9cnico Nacional, Ciudad de M\u00e9xico 07340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzia","family":"Padilla\u2011Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Laboratorio de Qu\u00edmica Supramolecular y Nanociencias, Unidad Profesional Interdisciplinaria de Biotecnolog\u00eda, Instituto Polit\u00e9cnico Nacional, Ciudad de M\u00e9xico 07340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana","family":"Cabrera\u2011Licona","sequence":"additional","affiliation":[{"name":"State Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS\u2011BIENESTAR), Colima 28085, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Espinosa\u2011Gil","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Delgado\u2011Enciso","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mart\u00ednez\u2011Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Faculty of Chemical Sciences, University of Colima, Coquimatl\u00e1n 28400, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"key20241209123715_b1-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41416-021-01328-7","article-title":"Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression","volume":"125","author":"L\u00fc\u00f6nd","year":"2021","journal-title":"Br J Cancer"},{"issue":"33","key":"key20241209123715_b2-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-017-0140-9","article-title":"Awareness and current knowledge of breast cancer","volume":"50","author":"Akram","year":"2017","journal-title":"Biol Res"},{"issue":"627","key":"key20241209123715_b3-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030627","article-title":"Chemotherapy side-effects: Not All DNA damage is equal","volume":"14","author":"van den Boogaard","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1414","key":"key20241209123715_b4-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20241209123715_b5-BR-22-1-01884","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5937\/arhfarm71-30618","article-title":"Medicinal chemistry of histone deacetylase inhibitors","volume":"71","author":"Ru\u017ei\u0107","year":"2021","journal-title":"Arh Farm"},{"key":"key20241209123715_b6-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.1096\/fj.14-250654","article-title":"Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators","volume":"28","author":"Yang","year":"2014","journal-title":"FASEB J"},{"issue":"875824","key":"key20241209123715_b7-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/875824","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Sakamoto","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"key20241209123715_b8-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-12-394387-3.00005-7","article-title":"Intrinsic and extrinsic apoptotic pathway signaling as determinants of histone deacetylase inhibitor antitumor activity","volume":"116","author":"Matthews","year":"2012","journal-title":"Adv Cancer Res"},{"key":"key20241209123715_b9-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","article-title":"Recent developments of HDAC inhibitors: Emerging indications and novel molecules","volume":"87","author":"Bondarev","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"key20241209123715_b10-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1078155216634178","article-title":"Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma","volume":"23","author":"Campbell","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"115212","key":"key20241209123715_b11-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115212","article-title":"Anticancer clinical efficiency and stochastic mechanisms of belinostat","volume":"165","author":"El Omari","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"5089371","key":"key20241209123715_b12-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5089371","article-title":"CXCL1 clone evolution induced by the HDAC inhibitor belinostat might be a favorable prognostic indicator in triple-negative breast cancer","volume":"2021","author":"Han","year":"2021","journal-title":"Biomed Res Int"},{"key":"key20241209123715_b13-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"121","DOI":"10.15537\/smj.2024.45.2.20230478","article-title":"Investigation of the effect of belinostat on MCF-7 breast cancer stem cells via the Wnt, Notch, and Hedgehog signaling pathway","volume":"45","author":"Tuncer","year":"2024","journal-title":"Saudi Med J"},{"key":"key20241209123715_b14-BR-22-1-01884","doi-asserted-by":"crossref","first-page":"941","DOI":"10.5455\/annalsmedres.2020.07.747","article-title":"Apoptotic effect of belinostat (PXD101) on MCF-7 cancer cells","volume":"28","author":"Tuncer","year":"2021","journal-title":"Ann Med Res"},{"key":"key20241209123715_b15-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1080\/21691401.2019.1671855","article-title":"Belinostat suppresses cell proliferation by inactivating Wnt\/\u03b2-catenin pathway and promotes apoptosis through regulating PKC pathway in breast cancer","volume":"47","author":"Lu","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"250","key":"key20241209123715_b16-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23020250","article-title":"Coumarin: A natural, privileged and versatile scaffold for bioactive compounds","volume":"23","author":"Stefanachi","year":"2018","journal-title":"Molecules"},{"issue":"2413","key":"key20241209123715_b17-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28052413","article-title":"Therapeutic effects of coumarins with different substitution patterns","volume":"28","author":"Flores-Morales","year":"2023","journal-title":"Molecules"},{"issue":"2569","key":"key20241209123715_b18-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24142569","article-title":"Design, synthesis and biological evaluation of novel coumarin-based hydroxamate derivatives as histone deacetylase (Hdac) inhibitors with antitumor activities","volume":"24","author":"Yang","year":"2019","journal-title":"Molecules"},{"issue":"690","key":"key20241209123715_b19-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/ph15060690","article-title":"Dihydropyrazole-carbohydrazide derivatives with dual activity as antioxidant and anti-proliferative drugs on breast cancer targeting the HDAC6","volume":"15","author":"Balbuena-Rebolledo","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"612647","key":"key20241209123715_b20-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/612647","article-title":"Evaluation of genotoxic and cytotoxic effects in human peripheral blood lymphocytes exposed in vitro to neonicotinoid insecticides news","volume":"2012","author":"Calder\u00f3n-Segura","year":"2012","journal-title":"J Toxicol"},{"key":"key20241209123715_b21-BR-22-1-01884","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s43450-023-00467-7","article-title":"Antitumor effects of annopurpuricin A, an acetogenin from the roots of annona purpurea","volume":"34","author":"Hern\u00e1ndez-Fuentes","year":"2024","journal-title":"Rev Bras Farmacogn"},{"key":"key20241209123715_b22-BR-22-1-01884","first-page":"1165","article-title":"Search for the pharmacophore of histone deacetylase inhibitors using pharmacophore query and docking study","volume":"13","author":"Haji Agha Bozorgi","year":"2014","journal-title":"Iran J Pharm Res"},{"issue":"945","key":"key20241209123715_b23-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040945","article-title":"Hydroxamic acid-based histone deacetylase (HDAC) inhibitors bearing a pyrazole scaffold and a cinnamoyl linker","volume":"20","author":"Zagni","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20241209123715_b24-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.4155\/fmc-2018-0587","article-title":"Design, synthesis and evaluation of belinostat analogs as histone deacetylase inhibitors","volume":"11","author":"Zhang","year":"2019","journal-title":"Future Med Chem"},{"key":"key20241209123715_b25-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cmdc.201500486","article-title":"Why hydroxamates may not be the best histone deacetylase inhibitors-what some may have forgotten or would rather forget?","volume":"11","author":"Shen","year":"2016","journal-title":"ChemMedChem"},{"key":"key20241209123715_b26-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"key20241209123715_b27-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/ml300081u","article-title":"Discovery of HDAC inhibitors that lack an active site Zn(2+)-binding functional group","volume":"3","author":"Vickers","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"key20241209123715_b28-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1021\/acsomega.6b00481","article-title":"Hydroxyl ketone-based histone deacetylase inhibitors to gain insight into class I HDAC selectivity versus that of HDAC6","volume":"2","author":"Traor\u00e9","year":"2017","journal-title":"ACS Omega"},{"key":"key20241209123715_b29-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1021\/acs.jmedchem.0c02150","article-title":"Discovery of zthyl ketone-based highly selective HDACs 1, 2, 3 inhibitors for HIV latency reactivation with minimum cellular potency serum shift and reduced hERG activity","volume":"64","author":"Yu","year":"2021","journal-title":"J Med Chem"},{"key":"key20241209123715_b30-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1021\/acs.biochem.9b00934","article-title":"Structural basis of catalysis and inhibition of HDAC6 CD1, the enigmatic catalytic domain of histone deacetylase 6","volume":"58","author":"Osko","year":"2019","journal-title":"Biochemistry"},{"key":"key20241209123715_b31-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nchembio.1223","article-title":"Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group","volume":"9","author":"Lobera","year":"2013","journal-title":"Nat Chem Biol"},{"key":"key20241209123715_b32-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"10462","key":"key20241209123715_b33-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67112-4","article-title":"Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines","volume":"10","author":"Sixto-L\u00f3pez","year":"2020","journal-title":"Sci Rep"},{"issue":"127023","key":"key20241209123715_b34-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127023","article-title":"Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6","volume":"30","author":"Osko","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"issue":"3677","key":"key20241209123715_b35-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123677","article-title":"Synthesis, optical characterization in solution and solid-state, and DFT calculations of 3-acetyl and 3-(1'-(2'-phenylhydrazono)ethyl)-coumarin-(7)-substituted derivatives","volume":"27","author":"Villa-Mart\u00ednez","year":"2022","journal-title":"Molecules"},{"key":"key20241209123715_b36-BR-22-1-01884","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/mrc.909","article-title":"1H and 13C NMR assignments of 2-oxo-2H-1-benzopyran-3-acyl and -3-amide derivatives","volume":"39","author":"Mart\u00ednez-Mart\u00ednez","year":"2001","journal-title":"Magn Reson Chem"},{"key":"key20241209123715_b37-BR-22-1-01884","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/cg0255826","article-title":"\u03c0-Stacking Interactions and CH\u00b7\u00b7\u00b7X (X=O, Aryl) hydrogen bonding as directing features of the supramolecular self-association in 3-carboxy and 3-amido coumarin derivatives","volume":"3","author":"Garc\u00eda-B\u00e1ez","year":"2003","journal-title":"Cryst Growth Des"},{"key":"key20241209123715_b38-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","article-title":"A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)","volume":"30","author":"Shen","year":"2020","journal-title":"Expert Opin Ther Pat"},{"key":"key20241209123715_b39-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/acs.jmedchem.8b01090","article-title":"Synthesis and biological investigation of phenothiazine-based benzhydroxamic acids as selective histone deacetylase 6 inhibitors","volume":"62","author":"V\u00f6gerl","year":"2019","journal-title":"J Med Chem"},{"key":"key20241209123715_b40-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1021\/acs.jmedchem.1c00184","article-title":"Harnessing the role of HDAC6 in idiopathic pulmonary fibrosis: Design, synthesis, structural analysis, and biological evaluation of potent inhibitors","volume":"64","author":"Campiani","year":"2021","journal-title":"J Med Chem"},{"key":"key20241209123715_b41-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1021\/acsmedchemlett.0c00395","article-title":"Spiroindoline-capped selective HDAC6 inhibitors: Design, synthesis, structural analysis, and biological evaluation","volume":"11","author":"Saraswati","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"3335","key":"key20241209123715_b42-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103335","article-title":"Design, synthesis, bioactivity evaluation, crystal structures, and in silico studies of new \u03b1-amino amide derivatives as potential histone deacetylase 6 inhibitors","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"issue":"13370","key":"key20241209123715_b43-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40232-3","article-title":"Developing multitarget coumarin based anti-breast cancer agents: Synthesis and molecular modeling study","volume":"13","author":"Takla","year":"2023","journal-title":"Sci Rep"},{"key":"key20241209123715_b44-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ejmech.2015.04.014","article-title":"Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids","volume":"96","author":"Sodji","year":"2015","journal-title":"Eur J Med Chem"},{"key":"key20241209123715_b45-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"6962","DOI":"10.1158\/1078-0432.CCR-04-0455","article-title":"HDAC6 expression is correlated with better survival in breast cancer","volume":"10","author":"Zhang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20241209123715_b46-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejcb.2010.09.004","article-title":"HDAC6 is required for invadopodia activity and invasion by breast tumor cells","volume":"90","author":"Rey","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"key20241209123715_b47-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3892\/or.2011.1236","article-title":"Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer","volume":"25","author":"Park","year":"2011","journal-title":"Oncol Rep"},{"key":"key20241209123715_b48-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1039\/d0md00317d","article-title":"Normal breast epithelial MCF-10A cells to evaluate the safety of carbon dots","volume":"12","author":"Vale","year":"2020","journal-title":"RSC Med Chem"},{"key":"key20241209123715_b49-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ijc.2910500323","article-title":"Characterization of epithelial phenotypes in mortal and immortal human breast cells","volume":"50","author":"Paine","year":"1992","journal-title":"Int J Cancer"},{"key":"key20241209123715_b50-BR-22-1-01884"},{"key":"key20241209123715_b51-BR-22-1-01884","doi-asserted-by":"publisher","first-page":"598","DOI":"10.24875\/GMM.M21000496","article-title":"Importance of the list of essential medicines in medical prescription","volume":"156","author":"Jasso","year":"2020","journal-title":"Gac Med Mex"},{"issue":"115323","key":"key20241209123715_b52-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"105454","key":"key20241209123715_b53-BR-22-1-01884","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105454","article-title":"The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis","volume":"121","author":"Nauta","year":"2021","journal-title":"Oral Oncol"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T10:37:25Z","timestamp":1733740645000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2024.1884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2024.1884","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"article-number":"6"}}